These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17395394)

  • 1. Association between serum testosterone levels and the severity of negative symptoms in male patients with chronic schizophrenia.
    Ko YH; Jung SW; Joe SH; Lee CH; Jung HG; Jung IK; Kim SH; Lee MS
    Psychoneuroendocrinology; 2007 May; 32(4):385-91. PubMed ID: 17395394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testosterone in first-episode schizophrenia.
    Cesková E; Prikryl R; Kaspárek T
    Neuro Endocrinol Lett; 2007 Dec; 28(6):811-4. PubMed ID: 18063925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative correlation between negative symptoms of schizophrenia and testosterone levels.
    Goyal RO; Sagar R; Ammini AC; Khurana ML; Alias AG
    Ann N Y Acad Sci; 2004 Dec; 1032():291-4. PubMed ID: 15677432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-serine serum levels in patients with schizophrenia: relation to psychopathology and comparison to healthy subjects.
    Hons J; Zirko R; Ulrychova M; Cermakova E; Libiger J
    Neuro Endocrinol Lett; 2008 Aug; 29(4):485-92. PubMed ID: 18766161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between testosterone, gonadotropins and prolactin and severity of negative symptoms in male patients with chronic schizophrenia.
    Akhondzadeh S; Rezaei F; Larijani B; Nejatisafa AA; Kashani L; Abbasi SH
    Schizophr Res; 2006 Jun; 84(2-3):405-10. PubMed ID: 16545544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triiodothyronine may be possibly associated with better cognitive function and less extrapyramidal symptoms in chronic schizophrenia.
    Ichioka S; Terao T; Hoaki N; Matsushita T; Hoaki T
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):170-4. PubMed ID: 22750309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevation of the cortisol/dehydroepiandrosterone ratio in schizophrenia patients.
    Ritsner M; Maayan R; Gibel A; Strous RD; Modai I; Weizman A
    Eur Neuropsychopharmacol; 2004 Aug; 14(4):267-73. PubMed ID: 15163435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative mechanisms in schizophrenia and their relationship with illness subtype and symptom profile.
    Pazvantoglu O; Selek S; Okay IT; Sengul C; Karabekiroglu K; Dilbaz N; Erel O
    Psychiatry Clin Neurosci; 2009 Oct; 63(5):693-700. PubMed ID: 19788631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen, menstrual cycle phases, and psychopathology in women suffering from schizophrenia.
    Bergemann N; Parzer P; Runnebaum B; Resch F; Mundt C
    Psychol Med; 2007 Oct; 37(10):1427-36. PubMed ID: 17451629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between lower urinary tract symptoms and serum levels of sex hormones in men.
    Miwa Y; Kaneda T; Yokoyama O
    Urology; 2008 Sep; 72(3):552-5. PubMed ID: 18597822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in DHEA metabolism in schizophrenia: two-month case-control study.
    Ritsner M; Gibel A; Ram E; Maayan R; Weizman A
    Eur Neuropsychopharmacol; 2006 Feb; 16(2):137-46. PubMed ID: 16139994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender-specific associations of depression with positive and negative symptoms in acute schizophrenia.
    Müller MJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1095-100. PubMed ID: 17493732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma testosterone and dehydroepiandrosterone sulfate in male and female patients with dysthymic disorder.
    Markianos M; Tripodianakis J; Sarantidis D; Hatzimanolis J
    J Affect Disord; 2007 Aug; 101(1-3):255-8. PubMed ID: 17182106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonadal hormones in schizophrenia and mood disorders.
    Ozcan ME; Banoglu R
    Eur Arch Psychiatry Clin Neurosci; 2003 Aug; 253(4):193-6. PubMed ID: 12910350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neurological soft signs in schizophrenic patients and their nonaffected siblings].
    Mechri A; Slama H; Bourdel MC; Chebel S; Mandhouj O; Krebs MO; Gaha L
    Encephale; 2008 Oct; 34(5):483-9. PubMed ID: 19068337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depression, emotional blunting, and akinesia in schizophrenia. Overlap and differentiation.
    Müller MJ; Kienzle B; Dahmen N
    Eur J Health Econ; 2002 Nov; 3 Suppl 2():S99-103. PubMed ID: 15609162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycine serum level in schizophrenia: relation to negative symptoms.
    Hons J; Zirko R; Ulrychova M; Cermakova E; Doubek P; Libiger J
    Psychiatry Res; 2010 Apr; 176(2-3):103-8. PubMed ID: 20096465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulatory neurosteroid levels in smoking and non-smoking chronic schizophrenia patients.
    Iancu I; Tchernihovsky E; Maayan R; Poreh A; Dannon P; Kotler M; Weizman A; Strous RD
    Eur Neuropsychopharmacol; 2007 Jul; 17(8):541-5. PubMed ID: 17346944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. State and trait related predictors of serum cortisol to DHEA(S) molar ratios and hormone concentrations in schizophrenia patients.
    Ritsner M; Gibel A; Maayan R; Ratner Y; Ram E; Modai I; Weizman A
    Eur Neuropsychopharmacol; 2007 Mar; 17(4):257-64. PubMed ID: 17107774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term testosterone augmentation in male schizophrenics: a randomized, double-blind, placebo-controlled trial.
    Ko YH; Lew YM; Jung SW; Joe SH; Lee CH; Jung HG; Lee MS
    J Clin Psychopharmacol; 2008 Aug; 28(4):375-83. PubMed ID: 18626263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.